These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21467599)

  • 21. Essentials for starting a pediatric clinical study (4): Clinical pediatric safety planning based on preclinical toxicity studies and pediatric pharmacovigilance guidance.
    Sheth N
    J Toxicol Sci; 2009; 34 Suppl 2():SP327-9. PubMed ID: 19571487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.
    Hartford CG; Petchel KS; Mickail H; Perez-Gutthann S; McHale M; Grana JM; Marquez P
    Drug Saf; 2006; 29(8):657-73. PubMed ID: 16872240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge, Attitudes, and Practices of Pharmacovigilance and ADRs Spontaneous Reporting Among Pediatricians and Pediatric Residents in Jordan.
    Mukattash TL; Alwadi MW; Abu-Farha RK; Jarab AS; Al-Zubiedi SA; Alwedyan T
    Curr Clin Pharmacol; 2018; 13(1):45-54. PubMed ID: 29521246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacoepidemiology and its input to pharmacovigilance.
    Faillie JL; Montastruc F; Montastruc JL; Pariente A
    Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Importance and specificity of pharmacovigilance in the pediatric population].
    Rodieux F; Ing-Lorenzini K; Rollason V
    Rev Med Suisse; 2019 Apr; 15(645):743-747. PubMed ID: 30942973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ceará State Pharmacovigilance System: a year of experience].
    Coêlho HL; Arrais PS; Gomes AP
    Cad Saude Publica; 1999; 15(3):631-40. PubMed ID: 10502160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
    Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
    Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adverse drug reaction surveillance system in Korea].
    Choi NK; Park BJ
    J Prev Med Public Health; 2007 Jul; 40(4):278-84. PubMed ID: 17693730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods for the detection of adverse drug reactions in hospitalized children: a systematic review.
    Ramos SF; Alvarez NR; Dos Santos Alcântara T; Sanchez JM; da Costa Lima E; de Lyra Júnior DP
    Expert Opin Drug Saf; 2021 Oct; 20(10):1225-1236. PubMed ID: 33926346
    [No Abstract]   [Full Text] [Related]  

  • 33. The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization.
    Smith MY; Benattia I
    Drug Saf; 2016 Sep; 39(9):779-85. PubMed ID: 27098248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Completeness of pharmacovigilance reporting in general medicine in France.].
    Humbert X; Jacquot J; Alexandre J; Sassier M; Robin N; Pageot C; Kheloufi F; Joyau C; Coquerel A; Durrieu G; Fedrizzi S
    Sante Publique; 2019; Vol. 31(4):561-566. PubMed ID: 31959257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmarketing surveillance.
    Vlahović-Palčevski V; Mentzer D
    Handb Exp Pharmacol; 2011; 205():339-51. PubMed ID: 21882120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.
    Ribeiro-Vaz I; Silva AM; Costa Santos C; Cruz-Correia R
    BMC Med Inform Decis Mak; 2016 Mar; 16():27. PubMed ID: 26926375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
    Mulchandani R; Kakkar AK
    Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation.
    Tan Y; Hu Y; Liu X; Yin Z; Chen XW; Liu M
    Methods; 2016 Nov; 110():14-25. PubMed ID: 27485605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dealing with adverse drug reactions in dentistry. Procedures on encountering adverse drug reactions and goal of the Swiss Pharmacovigilance system].
    Egger SS; Krähenbühl S; Schlienger RG
    Schweiz Monatsschr Zahnmed; 2005; 115(12):1209-18. PubMed ID: 16408825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.